Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
Título
Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
Autor
Solomon Habtemariam, Ioana Berindan-Neagoe, Maciej Banach, Mahdi Bagheri, Morteza Izadi, Emilio Clementi, Mahsa Rasekhian, Mohammad Bagheri, Seyed Nabavi, Cosmin Cismaru
Fecha
2020
Identificador
DOI: 10.5114/aoms.2020.94504
Fuente
Archives of Medical Science
Editor
Termedia Publishing House
Cobertura
Medicine
Archivos
Colección
Citación
Solomon Habtemariam, Ioana Berindan-Neagoe, Maciej Banach, Mahdi Bagheri, Morteza Izadi, Emilio Clementi, Mahsa Rasekhian, Mohammad Bagheri, Seyed Nabavi, Cosmin Cismaru, “Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2,” SOCICT Open, consulta 19 de abril de 2026, https://socictopen.socict.org/items/show/3745.
Position: 16999 (18 views)